Cytena
  1. Companies
  2. Cytena
  3. Articles
  4. Automating Cell Washing for GMP Cell ...

Automating Cell Washing for GMP Cell Therapy Manufacturing

SHARE
Mar. 27, 2026
Courtesy ofCytena

In GMP cell therapy manufacturing, manual washing introduces variability and increases documentation burden, whereas automated, closed or semi-closed washing enhances recovery, reduces contamination risk, and supports electronic batch records.

In cell therapy, the cell is the product. Each wash step impacts viability and yield. When starting material is limited, even small losses can prevent a batch from meeting release criteria. Washing processes in GMP environments must be repeatable, traceable, and defensible in audits.

Why manual washing is a liability under GMP

  • Operator variability: aspiration technique changes recovery and residual carryover.
  • Open handling: every open step increases contamination risk and requires additional controls.
  • Documentation load: temperatures, times, speeds, volumes, deviations, and operator actions must be captured and reviewed.
  • Scale effects: performance differences between small tubes and larger vessels or higher-throughput runs.

What automated cell washing needs to provide

  • Consistent recovery and residual removal across operators and shifts.
  • Clear parameter logging (spin speed, time, volumes, operator ID, timestamps).
  • Defined failure handling and alarms for deviations.
  • Compatibility with your facility flow and cleaning strategy.

Centrifugal decanting in an automated workflow

Centrifugal decanting removes supernatant without introducing a pipette tip into the vessel. The CYTENA C.WASH PLUS implements this approach and can log process parameters to support electronic batch records. The practical value is reduced operator-dependent aspiration variability and fewer contamination pathways by limiting open handling steps.

Use a validation mindset

Any equipment change in GMP requires validation. Plan early for IQ/OQ/PQ expectations and for how data will be captured and archived. Treating washing as a critical process step simplifies justification of investment and strengthens audit defense.

Key takeaways

  • Manual washing creates variability and contamination risk that training alone cannot eliminate.
  • Automation can improve recovery and make parameter logging routine rather than manual.
  • Plan validation and data integration early so equipment supports GMP documentation, not just biology.
Original: https://www.cytena.com/resource-hub/blog/automating-cell-washing-for-gmp-cell-therapy-manufacturing/
Most popular related searches